Archives

Terms of Use
HIPAA Privacy Practices Notice

Connective tissue supplementation and tissue transplant products are classified by the Food and Drug Administration (FDA) as
Human Cell, Tissue and Cellular and Tissue-Based Products (HCT/P) that are regulated solely under section 361 of the Public
Health Service (PHS) Act. FDA recognizes that human tissue was designed, or evolved, to perform certain functions in the human
body with exquisite safety and effectiveness. As an HCT/P regulated solely under Section 361 of the PHS Act, these products are
exempt from FDA pre-market review, clearance, and approval from FDA. No medical advice has been offered herein. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Results may vary.